HLA-A - Wikipedia
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia: Molecular Therapy Methods & Clinical Development
JCI - Poor immunogenicity of a self/tumor antigen derives from peptide–MHC-I instability and is independent of tolerance
Methodology for immunoprecipitation of HLA-A2 molecules, elution of... | Download Scientific Diagram
Characteristics of HLA-A2-positive lymphoma cell lines | Download Table
Identification of HLA‐A2 restricted CD8+ T cell epitopes in SARS‐CoV‐2 structural proteins - Deng - 2021 - Journal of Leukocyte Biology - Wiley Online Library
Frontiers | Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance
Mesothelin-specific CD8 T cells in HLA-A2 positive patients are... | Download Scientific Diagram
Recognition of different HLA-A2-positive target cells by... | Download Scientific Diagram
Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection - ScienceDirect
Lysis of human HLA-A2-positive tumor cells by Bax peptide-specific CTL | Download Table
Biotin anti-human HLA-A2
Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer | British Journal of Cancer
Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes | Journal of the American Chemical Society
HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China | PLOS ONE
Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes | PNAS
Viruses | Free Full-Text | How much of Virus-Specific CD8 T Cell Reactivity is Detected with a Peptide Pool when Compared to Individual Peptides?
Cancers | Free Full-Text | Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA
HLA-based therapeutics: an entire drug pipeline is based on a patient's race.
B-HLA-A2.1 mice_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery
APC Mouse Anti-Human HLA-A2
Frontiers | Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance
Identification of an HLA-A2-restricted CD147 epitope that can induce specific CTL cytotoxicity against drug resistant MCF-7/Adr cells
Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer
